Drugs / CIFENLINE
last change Jun 2006 re-read 2 minutes ago

CIFENLINE

Small molecule

Developed for
paroxysmal atrial fibrillation

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00540787 Comparator Aug 2003 → Jun 2006 paroxysmal atrial fibrillation Biosense Webster, Inc. Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CIFENLINE ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as Cibenol ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as Cibenzolina ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as cibenzoline ClinicalTrials.gov intervention name — accepted as the source's own label NCT00540787
Known as Cibenzoline succinate ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as CIFENLINE SUCCINATE ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as Cipralan ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as RO 22-7796 ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Known as RO 22-7796/001 ChEMBL registry synonym — accepted as the source's own label CHEMBL87045
Modality Small molecule CHEMBL87045